Foresee Genomics

Company Overview

Snapshot

Founded in August 2017 by Arnon Chait and Roi Feingersch, Foresee Genomics operates with 1–10 employees. The company has raised $2.1 million across four funding rounds from three investors.

Business overview

Foresee Genomics is a Health Tech & Life Sciences company focused on developing DNA testing systems for cancer patients. The company's core technology combines molecular biology and computational analysis to provide physicians with genetic data for determining treatment options. Their procedure utilizes a low-cost nanopore sequencing platform, aiming to deliver accurate and affordable end-to-end genomic diagnostics at the point of care in hospitals and local clinics. Foresee Genomics operates within the Digital Healthcare sector, specifically in Digital Medical Diagnostics, serving healthcare providers.

Company Intelligence Q&A

When was Foresee Genomics founded?

Foresee Genomics was founded in August 2017.

Who are the founders of Foresee Genomics?

The founders of Foresee Genomics are Arnon Chait and Roi Feingersch.

What is Foresee Genomics' primary focus?

Foresee Genomics primarily focuses on cancer genomics diagnostics, developing DNA testing systems that combine molecular biology and computational analysis to aid physicians in determining treatment options.

What type of technology does Foresee Genomics utilize?

Foresee Genomics utilizes a nanopore sequencing platform for its DNA testing system, which is designed to be a significantly inexpensive alternative to other Next-Generation Sequencing (NGS) platforms for genomic diagnostics.